JCEM: Thoracic fractures are common and predictable disease prognosis in PATIENT-19 patients.

COVID-19 has become the world's most concerned medical issue.
although several studies have looked at clinical characteristics in patients with COVID-19, there has been no data on the prevalence of vertebral fractures (VFs).
VF may affect cardiopulmonary function and disease outcomes, a recent study published in Journal of Clinical Endocrinology and Metabolism, an authoritative journal in the field of endocrine and metabolic diseases, aims to assess the prevalence of VF and its effects on clinical outcomes in patients with COVID-19.
a retrospective cohort study conducted at a level 3 medical hospital in Italy, the researchers included COVID-19 patients who were treated in the emergency department and had a lateral chest X-ray.
researchers used chest X-rays to semi-quantitatively assess vertebral shapes to detect the use of VF.
the study included 114 patients, 41 of whom (36%) detected chest VF.
patients with VF are older and more susceptible to hypertension and coronary artery disease (p.lt;0.001, p.007, p-0.034, respectively).
36 patients (88%) were admitted to the VFs group, while 54 patients (74%) were admitted in the non-VFs group (p-0.08).
patients with VF were more likely to need non-invasional mechanical breathing (p-0.02) than patients without VF.
mortality rate was 22 per cent in the VFs group and 10 per cent in the VFs-free group (p=0.07).
mortality was higher in patients with severe VF than in patients with moderate and mild VF (p-0.04).
, VFs may have integrated cardiopulmonary risk in COVID-19 patients, a useful and easy clinical indicator for measuring vulnerability and poor prognosticity.
suggest that all patients with suspected COVID-19 who undergo chest X-rays should be evaluated for thoracic morphology.
.